Harvard

Access to higher levels of residential greenspace was tied to lower adiposity in children, according to findings published in JAMA Network Open.

A higher plant-to-animal protein ratio was associated with lower risks for CVD and CAD among adults in three ongoing U.S. prospective cohort studies, according to a study published in the American Journal of Clinical Nutrition.

Despite tremendous progress in lung cancer treatment and survival the past few decades, one startling trend has emerged.

SAN DIEGO — A multidrug combination significantly improved survival for certain patients with leukemia compared with standard chemoimmunotherapy, according to results of the randomized phase 3 AMPLIFY study.

SAN DIEGO — Rilzabrutinib induced “fast” and “persistent” platelet count expansion for heavily treated individuals with immune thrombocytopenia, according to results of the randomized phase 3 LUNA 3 study.

In this video, John H. Stone, MD, MPH, professor of medicine at Harvard Medical School, the Edward A. Fox Chair in Medicine at Massachusetts General Hospital, discusses an important facet of IgG4-related disease other rheumatologists and providers should be aware of.

A mind-body intervention program had positive effects on quality of life for people with cancer, according to a pilot study.

WASHINGTON — In this video, Jeffrey A. Sparks, MD, MMSc, spotlights a study evaluating the impact of remote monitoring of rheumatoid arthritis.

WASHINGTON — Healio spoke with Jeffrey A. Sparks, MD, MMSc, about baseline results from the SAIL-RA study, which assesses which patients with rheumatoid arthritis may be at risk for developing interstitial lung disease.

WASHINGTON — In this video, Jeffrey A. Sparks, MD, MMSc, highlights an observational study investigating the impact of disease-modifying antirheumatic drugs on rheumatoid arthritis-associated interstitial lung disease.